Viking Therapeutics, Inc.VKTXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-150.92M
↓ 188% below average
Average (9y)
$-52.42M
Historical baseline
Range
High:$-12.00M
Low:$-150.92M
CAGR
+32.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-150.92M | -49.7% |
| 2023 | $-100.83M | -43.3% |
| 2022 | $-70.36M | -26.4% |
| 2021 | $-55.68M | -30.5% |
| 2020 | $-42.66M | -30.5% |
| 2019 | $-32.69M | -24.9% |
| 2018 | $-26.16M | -37.2% |
| 2017 | $-19.07M | -37.7% |
| 2016 | $-13.85M | -15.4% |
| 2015 | $-12.00M | - |